The largest database of trusted experimental protocols

26 protocols using vancomycin

1

Antimicrobial Susceptibility Profiling of Staphylococci

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility assay was performed on all staphylococci according to the Clinical and Laboratory Standards Institute guidelines [44 ]. Sixteen antimicrobial agents were utilized for disc diffusion assays on Mueller–Hinton agar (MHA, Difco Laboratories): ampicillin (AMP, 10 μg), cefoxitin (FOX, 30 μg), penicillin (PEN, 10 μg), chloramphenicol (CHL, 30 μg), ciprofloxacin (CIP, 5 μg), enrofloxacin (ENR, 5 μg), levofloxacin (LEV, 5 μg), clindamycin (CLI, 2 μg), erythromycin (ERY, 15 μg), gentamicin (GEN, 10 μg), mupirocin (MUP, 200 μg), rifampicin (RIF, 5 μg), sulfamethoxazole-trimethoprim (SXT, 23.75/1.25 μg), quinupristin-dalfopristin (SYN, 15 μg), and tetracycline (TET, 30 μg). mupirocin was purchased from Oxoid (Hampshire, UK), and the rest of the antimicrobial agents were purchased from BD BBLTM (Becton Dickinson, Franklin Lakes, NJ). The minimum inhibitory concentrations (MICs) of oxacillin (OXA), TET, CIP, and ENR were determined for all the study strains by using the standard two-fold broth microdilution [44 ]. The MICs of the study strains to vancomycin (VAN) and linezolid (LZD) were determined by standard Etest (AB Biodisk, Dalvagen, Sweden). S. aureus MW2 and S. aureus ATCC 29213 strains were used as reference strains for the antimicrobial susceptibility tests. All antimicrobial susceptibility tests were repeated three times.
+ Open protocol
+ Expand
2

Antibiotic Resistance Profiling of S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
The resistance of S. aureus isolates to antimicrobial agents was determined by disk diffusion and interpreted according to the CLSI document no. M02-A11.14 The following drugs were used for the test: penicillin, erythromycin, azithromycin, roxithromycin, clindamycin, lincomycin, ciprofloxacin, ofloxacin, levofloxacin, tetracycline, amikacin, tobramycin, netilmicin, gentamicin, fusidic acid, sulfamethoxazole/trimethoprim, chloramphenicol, vancomycin (all from Becton Dickinson, Franklin Lakes, NJ, USA) and mupirocin (Oxoid). Multidrug resistance was defined as resistance to antimicrobial agents from at least three various classes. For isolates identified as resistant to erythromycin but susceptible to clindamycin, D-test was performed to detect inducible clindamycin resistance. Minimal inhibitory concentration (MIC) for vancomycin was determined by E-tests, in line with the manufacturer’s instructions (AB Biodisk, Solna, Sweden).
+ Open protocol
+ Expand
3

Vancomycin Susceptibility of MRSA

Check if the same lab product or an alternative is used in the 5 most similar protocols
All S. aureus isolates were identified using standard methods. Methicillin resistance was confirmed by polymerase chain reaction (PCR) detection of the mecA gene. Vancomycin MICs of methicillin-resistant S. aureus (MRSA) isolates were determined by the Vancomycin Etest (AB Biodisk, Piscataway, NJ, USA) on Mueller-Hinton agar according to the manufacturer's instructions.
+ Open protocol
+ Expand
4

Antimicrobial Susceptibility Testing of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility testing was performed using the disk diffusion method on Muller-Hinton agar (Difco, Detroit, MI, USA) according to the recommendation to the guidelines of the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2017) (http://www.eucast.org/, accesed on 9 January 2017) [30 ]. A total of 17 antibiotics (Oxoid, Basingstoke, UK) were tested: oxacillin (OXA, 1 μg), cefoxitin (FOX, 30 μg), penicillin (P, 10 UI), gentamicin (CN, 10 μg), ciprofloxacin (CIP, 5 μg), erythromycin (E, 15 μg), clindamycin (DA, 2 μg), chloramphenicol (C, 30 μg), rifampin (RD, 5 μg), tetracycline (TE, 30 μg), vancomycin (VA, 30 μg), Teicoplanin (TEC, 30 μg), trimethoprim-sulfamethoxazole (SXT, 1.25/23.75 μg), quinupristin/dalfopristin (QDA, 15 μg), fosfomycin (FOS, 50 µg), linezolid (LNZ, 30 µg) and fusidic acid (FD, 10 µg).
The minimum inhibitory concentrations (MICs) for oxacillin and cefoxitin were determined by E-test (AB-biodisk, Dalvogen, Sweden) on Muller-Hinton agar (Difco, Detroit, MI, USA) and interpreted as recommended by EUCAST [30 ].
Isolates that presented resistance to three or more classes of antibiotics, other than beta-lactams, were classified as having a multidrug resistance profile [31 (link)].
+ Open protocol
+ Expand
5

Isolation and Identification of Enterococcus spp.

Check if the same lab product or an alternative is used in the 5 most similar protocols
Feces (a total of 25 g) were diluted 1:10 in Brain Heart Infusion (BHI, Difco Laboratories, Detroit, MI, USA) broth supplemented with sterile NaCl 6.5% and incubated at 37 ± 1°C for 18 to 24 h. Subsequently, 20 µL of the incubated broth was subcultured onto m-Enterococcus Agar (Difco Laboratories) for the selective isolation of Enterococcus spp. Simultaneously, for the selective isolation of vancomycin-resistant enterococci (VRE), 10 µL of the initial broth was subcultured on BHI broth supplemented with 2 mg/L vancomycin (Sigma-Aldrich, Saint Louis, MO, USA). After incubation (37 ± 1°C for 18 to 24 h), 20 µL was subcultured onto m-Enterococcus plates with vancomycin (6 mg/mL) and incubated at 37 ± 1°C for 18 to 24 h. Ten colonies per plate were selected based on colony morphology and subcultured onto Blood Agar (Columbia agar + 5% sheep blood, bioMérieux, Marcy-l’Etoile, France) for further identification of Efs and Efm by the simultaneous real-time PCR amplification of the mltF gene of Efs and the ddlA gene present in Efm (RTi-PCR1), as described elsewhere (16 (link)).
+ Open protocol
+ Expand
6

Antibiotic Susceptibility Testing of Staphylococcus aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibacterial susceptibility testing was performed by the disc diffusion method 21 with the following antimicrobial disks (Oxoid, Basingstoke, UK): benzyl penicillin (2 U), cefoxitin (30 μg), kanamycin (30 μg), mupirocin (200 μg and 5 μg), gentamicin (10 μg), erythromycin (15 μg), clindamycin (2 μg), chloramphenicol (30 μg), tetracycline (10 μg), trimethoprim (2.5 μg), fusidic acid (10 μg), rifampicin (5 μg), ciprofloxacin (5 μg), teicoplanin (30 μg), vancomycin (30 μg) and linezolid (30 μg). Discs containing cadmium acetate (50 μg), propamidine isethionate (100 μg) and mercuric chloride (109 μg) were prepared in the laboratory. Minimum inhibitory concentration (MIC) for cefoxitin, vancomycin and teicoplanin were determined with E-test strips (AB BioMérieux, Marcy l'Etoile, France) according to the manufacturer's instructions. Staphylococcus aureus strain ATCC25923 was used as a quality control strain for susceptibility testing.
+ Open protocol
+ Expand
7

Antimicrobial Susceptibility Testing for C. difficile

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial suspensions and MIC gradient stripes containing erythromycin, vancomycin, metronidazole, tetracycline and clindamycin (bioMérieux, Marcy l'Etoile, France; Oxoid; Himedia) were plated onto BD™ Brucella Blood Agar with Hemin and Vitamin K1 (Becton Dickinson) following the manufacturer's instructions. According to the recommendations of the Clinical and Laboratory Institute (CLSI), the following breakpoints for resistance were used: erythromycin and clindamycin 8 mg/L, tetracycline 16 mg/L, metronidazole 32 mg/L (CLSI, 2021 ; Spigaglia et al., 2011 (link)). CLSI‐approved clinical breakpoints for vancomycin were not available. The reference strain C. difficile ATCC®700057 was used as quality control strain.
+ Open protocol
+ Expand
8

Antibiotic Susceptibility Profiling of Staphylococcus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Susceptibility to penicillin G, gentamicin, rifampin, ciprofloxacin, clindamycin, erythromycin, chloramphenicol, tetracycline, linezolid, and vancomycin (National Institutes for Food and Drug Control, China) were tested by agar dilution method as described by Wiegand et al.23 In addition, the E‐test method was used to determine the MICs of all isolates for sulfamethoxazole/ trimethoprim (SXT) (bioMérieux, France). Mueller‐ Hinton agar (MHA) plates were inoculated by streaking the standardized inocula (0.5 McFarland, approximately 1.5 × 108 CFUs/mL) using a sterile swab. The SXT E‐test strips (bioMérieux, France) were placed on the plates, followed by incubation at 35°C for 16–20 h. The minimal inhibitory concentration (MIC) reading for both the E‐test and agar dilution methods was conducted independently by a senior experimenter, with the result confirmed by a second reader. The MIC results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) breakpoints for Staphylococcus spp.24Staphylococcus aureus ATCC29213 was used as a quality control. MDR was defined as isolates resistant to ≥3 classes of non‐β‐lactam antimicrobials.
+ Open protocol
+ Expand
9

Antibiotic Resistance Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Resistance to a set of other agents was assessed with the use of the disc diffusion (DD) method and the E-test method. The former (by Oxoid) was applied for penicillin (P); amikacin (AK); gentamycin (CN); ciprofloxacin (CIP); levofloxacin (LEV); mupirocin (MUP); fusidic acid (FUS); tetracycline (TET), and the latter (by BioMerieux) for ceftaroline (CPT); vancomycin (VA); teicoplanin (TP); linezolid (LZD); daptomycin (DPC); tigecycline (TGC); and spectinomycin (SC), according to the EUCAST guidelines [28 ,51 ].
+ Open protocol
+ Expand
10

Antibiotic Susceptibility of Marseille-P3237

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibiotic susceptibility of strain Marseille-P3237 was assessed using the E-test method for the following molecules: benzylpenicillin, amoxicillin, cefotaxime, ceftriaxone, imipenem, amikacin, erythromycin, daptomycin, rifampicin, minocycline, teicoplanin, vancomycin, colistin and metronidazole (bioMérieux).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!